Share Price:

APNASPENAspen Pharmacare Hldgs21701-219 (-1.00%)

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform to be released on 4 March 2024.

Quality Systems

Team Overview

The Aspen Quality Assurance Department, as well as various regulatory agencies, conduct audits of potential and existing suppliers to support the high-quality objectives and compliance with GMP across the supply chain.
All inspection findings are closely managed through to close-out, with critical findings receiving executive management oversight. Only products that meet the prescribed quality and regulatory standards are released for sale, and regulated quality compliance controls are in place.
 
The quality and efficacy of supplied products are monitored throughout the product lifecycle using systems approved and monitored by regulatory authorities. As the owner and/or holder of the marketing authorisation, we are responsible for the quality of our products across all territories.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam id nisl in urna euismod pellentesque vitae vitae mauris. Suspendisse faucibus ex sed convallis dignissim.

Name, Group Marketing Head

Working At Aspen

We believe that doing business in a sustainable and responsible manner is integral to our purpose, our values and our philosophy “Healthcare. We Care”.


Our sustainability commitments are integrated into the Group’s strategic objectives and underpin the way we do business.

 

Our sustainability commitments are integrated into the Group’s strategic objectives and underpin the way we do business.

Innovation

We constantly search for better ways of doing things

Excellence

We strive to be the best we can be to deliver the highest standards

Commitment

We go the extra mile, seeking to exceed expectations

Teamwork

We optimise our performance by pulling together

Integrity

Our integrity is not negotiable

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.